An Ozempic-style weight loss drug will be heavily subsidised for Australians with severe obesity and have experienced a cardiovascular event, like a heart attack or stroke.

People taking the most common GLP-1 drugs lost an average of 33 pounds while on treatment, but gained back about 22 pounds ...

GLP‑1 medications such as Ozempic and Wegovy work by mimicking a hormone that signals fullness to the brain and gut. But once ...

The convenience and lower cost of the oral pill may be critical to some patients, which could expand the market, improve ...

By Dennis Thompson HealthDay ReporterWEDNESDAY, Jan. 7, 2026 (HealthDay News) — Ozempic and Wegovy might help people avoid ...

A new analysis raises questions about long-term outcomes after popular weight-loss drugs are discontinued, with implications ...

It's going to cost taxpayers a lot of money — but the federal government says subsidising weight loss drug Wegovy is an ...

Weight loss jabs may have helped obesity patients shed kilos, but a new review finds that this weight is regained within two ...

Ozempic and Wegovy – two brand-name semaglutide drugs prescribed for diabetes and weight loss – will lose market exclusivity ...

Novo Nordisk’s new Wegovy pill hit the market this week. The Danish drug maker, best known for GLP-1 injections like Ozempic ...

Whether it’s due to an ingredient allergy or other reasons, compounding pharmacies can help tailor a custom-made medication to meet your needs. And when drug shortages happen, they can play an ...

Manufacturer Novo Nordisk is now offering Wegovy in pill form, which some people prefer to the injections. The company has ...